Subscribe to Newsletter
Subspecialties Oncology, Histology

Case of the Month

The following light microscopic images were obtained from colon specimens. The patient received a diagnosis of signet ring cell adenocarcinoma of the colon. In what organ is this condition most commonly diagnosed?

a. Colon
b. Rectum
c. Stomach
d. Bladder
e. Gallbladder

A) Hematoxylin and eosin 10x. Courtesy of Gang He.

B) Hematoxylin and eosin, 40x. Courtesy of Gang He.

Click here to register your guess.

Do you have an interesting case that you would like us to feature? Email it to [email protected].

b. 85 percent of GISTs are associated with KIT mutations

Gastrointestinal stromal tumor (GIST) is the most common mesenchymal tumor of the GI tract. Whereas 85 percent of GISTs are associated with KIT mutations, 10 percent are associated with PDGFRA mutations and a small proportion are associated with mutations in the succinate dehydrogenase (SDH), NF1, or BRAF genes.

This case show features diagnostic of gastrointestinal stromal tumor (GIST) arising from the duodenal wall. The tumor comprises fascicles and sheets of spindle cells with focal epithelioid morphology; small intestinal GISTs more commonly show skeinoid fibers. The cytological smears show bland spindle cells and few epithelioid cells. The tumor cells stain positive for c-Kit (CD117) and DOG1 by IHC; Sanger sequencing shows a KIT exon 9 mutation, making this tumor less susceptible to imatinib.

Submitted by Vishnu Chandra Kumar Annadurai, Fellowship Trainee in Molecular Pathology; Thomas Alex Kodiatte, Professor; and Rekha Pai, Professor, Christian Medical College, Vellore, India.

Receive content, products, events as well as relevant industry updates from The Pathologist and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

About the Authors
Erina McKinney

University of Kansas School of Medicine, Kansas City, Kansas, USA.


Gang He

Consultant pathologist at Harlem Hospital—Columbia University/NYU-LI Long Island Community Hospital, New York, USA.


Ting Zhao

Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Related Application Notes
Tumor Genomic Profiling with SureSelect Cancer Tumor-Specific Assays

| Contributed by Agilent

Comprehensive Genomic Profiling with SureSelect Cancer CGP Assay

| Contributed by Agilent

Preventing Bias in scRNAseq Performed on Solid Tumors

| Contributed by Revvity

Related Product Profile
Diagnostics Genetics and epigenetics
QIAseq® Pan Cancer Multimodal cuts user interventions by 50%

| Contributed by QIAGEN

Most Popular
Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register